In light of the arrows being flung at MNKD, the bottom like is approval and rapid adoption by diabetics who, for once, have an easy and pain free tool to help control their disease. The naysayers won't have any ammo left if Afrezza becomes the darling of diabetics.

Thanks for your thoughts and welcome back to the board.

What do you think has lead to the huge sell off?

The ANALysts is correct. Once the FDA approves, the real work will be in getting people to switch to Afrezza. That will be the biggest and most daunting hurdle.

Call me crazy but I am still holding my shares. I believe this is the tip of the iceberg and that we haven't seen the real mass of MNKD yet. As you know, we cleared an important hurdle today but there are more to come. The FDA is next. Hopefully there is a respectable big pharma out there that understands the huge potential of Afrezza and partners with MNKD to make Afrezza the go to therapy for diabetics around the world.

Eh, looks like the market wants to keep a lid on this and that good results were pretty much built into the stock. The way it's trending now, it won't close higher than it's high last week. That's sorta sad but the great news is the data was spot on. Onward and upwards for this stock. Hopefully Al will have some great nuggets later today.

While I hope this really pops today, the pre market action looks like there is going to be lid placed on MNKD today.

All in all, perfect news. The data obtained was spot on. Now the FDA has to do their damn job and approve this with an EXPANDED label.

This is great news for diabetics across the world.

It also proves how evil people are that they ignored the science and lied about the company and the science.